Dr Angela Rezo

FRANZCR MBBS (Hon) BSc (Med)
Radiation Oncologist
Refer a patient

Dr Angela Rezo is a radiation oncologist with 20 years of experience who is committed to delivering high quality modern cancer treatment and developing a strong therapeutic relationship with her patients. She is an active member of the breast, brain, and lung cancer multi-disciplinary teams in the ACT, and is a clinical leader for the stereotactic service at the Canberra Hospital. Dr Rezo strives to ensure patients receive individualised treatment recommendations according to the most up-to-date evidence.

Biography

Dr Angela Rezo graduated from medical school at the University of NSW in 1995 and trained in radiation oncology at Peter MacCallum Cancer Centre and at the Canberra Hospital, where she completed a Fellowship at the Australian National University (ANU) Medical School. She was awarded fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2005.

Dr Rezo has worked at the Canberra Hospital since 2004, where she has taken on numerous leadership positions including Director of Training, Acting Director of Radiation Oncology, Chair of the ACT and South East New South Wales Breast Cancer Treatment Group, Chair of the Neuro-oncology Multi-disciplinary Meeting (MDM), and has played a leading role in improving the quality of cancer care.

Dr Rezo has supervised numerous research projects, is a senior lecturer at the ANU Medical School and has been an examiner for the RANZCR radiation oncology training program. She is committed to life-long learning and attends regular conferences and workshops to keep up to date with the latest in cancer treatment. Dr Rezo is also the Principal Investigator and active recruiter to several clinical trials in breast and lung cancer.

Affiliations & Memberships

  • Royal Australian and New Zealand College of Radiologists (FRANZCR)
  • Trans-Tasman Radiation Oncology Group (TROG)
  • Cooperative Trials Group for Neuro-Oncology (COGNO)

Special Interests

  • Brain cancer
  • Breast cancer
  • Lung cancer
  • Palliative radiation therapy

Icon Locations

Canberra View centre

Publications

  • IHC4 score plus clinical treatment score predicts locoregional recurrence in early breast cancer. Lakhanpal R, Sestak I, Shadbolt B, Bennett GM, Brown M, Phillips T, Zhang Y, Bullman A, Rezo A. Breast. 2016 Oct;29:147-52. https://www.ncbi.nlm.nih.gov/pubmed/27498128

  • Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial. Pollock S, O’Brien R, Makhija K, Hegi-Johnson F, Ludbrook J, Rezo A, Tse R, Eade T, Yeghiaian-Alvandi R, Gebski V, Keall PJ. BMC Cancer. 2015 Jul 18;15:526. https://www.ncbi.nlm.nih.gov/pubmed/26187714

  • Numb chin syndrome: a case series of a clinical syndrome associated with malignancy. Tejani N, Cooper A, Rezo A, Pranavan G, Yip D. J Med Imaging Radiat Oncol. 2014 Dec;58(6):700-5. https://www.ncbi.nlm.nih.gov/pubmed/24966131

  • Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance Project. Behm EC, Beckmann KR, Dahlstrom JE, Zhang Y, Cho C, Stuart-Harris R, Craft P, Rezo A, Buckingham JM. Breast. 2013 Oct;22(5):839-44. https://www.ncbi.nlm.nih.gov/pubmed/23523179

  • Tumor size and survival in multicentric and multifocal breast cancer. Rezo A, Dahlstrom J, Shadbolt B, Rodins K, Zhang Y, Davis AJ; ACT & SENSW BCTG. Breast. 2011 Jun;20(3):259-63. https://www.ncbi.nlm.nih.gov/pubmed/21324695

  • Synchronous multiple ipsilateral breast cancers: implications for patient management. Jain S, Rezo A, Shadbolt B, Dahlstrom JE. Pathology. 2009 Jan;41(1):57-67. https://www.ncbi.nlm.nih.gov/pubmed/19089741

View all Doctors

Search